<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="373401">
  <stage>Registered</stage>
  <submitdate>31/07/2017</submitdate>
  <approvaldate>17/08/2017</approvaldate>
  <actrnumber>ACTRN12617001207303</actrnumber>
  <trial_identification>
    <studytitle>Effect of orally given pregabalin before knee joint replacement on incidence of bandage induced reperfusion injury</studytitle>
    <scientifictitle>Effect of pregabalin given preoperatively on the tourniquet induced ischemia-reperfusion injury during total knee arthroplasty surgery</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>none</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition> knee arhroplasty </healthcondition>
    <healthcondition>ischemia-reperfusion injury</healthcondition>
    <conditioncode>
      <conditioncode1>Anaesthesiology</conditioncode1>
      <conditioncode2>Other anaesthesiology</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Musculoskeletal</conditioncode1>
      <conditioncode2>Other muscular and skeletal disorders</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Patients will divide in two groups. We will give 150 mg pregabalin capsule orally 1 day before surgery and 1 hour before surgery (totally two times) to pregabalin group patients. In control group, we will empty the drug material from capsules and give only empty capsules to control group patients at the same times.</interventions>
    <comparator> In control group, we will empty the drug material from capsules and give only empty capsules to control group patients at the same times.</comparator>
    <control>Placebo</control>
    <interventioncode>Treatment: Drugs</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Determination effect of pregabalin on tourniquet induced ischemia reperfusion injury. For this purpose we will measure catalase, ischemic modified albumin, total antioxidant status, total oxidant status in blood samples.</outcome>
      <timepoint>we have three timepoints for measurements: Immediately before surgery, 5 minutes before tourniquet deflation, 20 minutes later tourniquet deflation</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Patient's anxiety levels will be evaluated. We will use visual analog scale for anxiety levels. </outcome>
      <timepoint>We have three timepoints for secondary outcome: 1 day before surgery just before given pregabalin first dose, just before second pregabalin dose, before patients go into operation room.</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>1) American Society of Anesthesiologists (ASA) physical status I-II 
2) Undergoing a total knee arthroplasty surgery
3) Accept neuroaxial anesthesia for surgery</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>65</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>1) Any antiepileptic drug use
2) Allergic reaction to pregabalin
3) Severe hepatic, renal or gastrointestinal disorders
4) Psychiatric disorders
5) Pregnant women or breastfeeding
6) NSAID or opioid drug use for a long time
7) Diabetic or other neuropathic pain</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Prevention</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment />
    <sequence />
    <masking />
    <assignment />
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry>False</patientregistry>
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase />
    <anticipatedstartdate />
    <actualstartdate>1/01/2017</actualstartdate>
    <anticipatedenddate />
    <actualenddate>25/07/2017</actualenddate>
    <samplesize>54</samplesize>
    <actualsamplesize>54</actualsamplesize>
    <currentsamplesize />
    <recruitmentstatus>Completed</recruitmentstatus>
    <anticipatedlastvisitdate />
    <actuallastvisitdate>25/07/2017</actuallastvisitdate>
    <dataanalysis />
    <withdrawnreason />
    <withdrawnreasonother />
    <recruitmentcountry>,Outside</recruitmentcountry>
    <recruitmentstate />
    <countryoutsideaustralia>
      <country>Turkey</country>
      <state>Konya</state>
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>University</primarysponsortype>
    <primarysponsorname>Baskent University</primarysponsorname>
    <primarysponsoraddress>Taskent Caddesi (Eski 1. Cadde) 77. Sokak (Eski 16. Sokak) No:11 06490 Bahcelievler / ANKARA</primarysponsoraddress>
    <primarysponsorcountry>Turkey</primarysponsorcountry>
    <fundingsource>
      <fundingtype>University</fundingtype>
      <fundingname>Baskent University</fundingname>
      <fundingaddress>Taskent Caddesi (Eski 1. Cadde) 77. Sokak (Eski 16. Sokak) No:11 06490 Bahcelievler / ANKARA</fundingaddress>
      <fundingcountry>Turkey</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>Extremity surgeries require tourniquet for a bloodless surgical area. But, tourniquet applications cause ischemia-reperfusion injury. Our aim in this study is to investigate effect of preoperatively given pregabalin, GABA analog drug, on the tourniquet induced ischemia-reperfusion injury.
54 patients between 18-65 years who undergo total knee arthroplasty participate the study. Criteria for inclusion are patients whom American Society of Anesthesiologists (ASA) physical status I-II, undergoing a total knee arthroplasty surgery, accept neuroaxial anesthesia for surgery. Criteria for exclusion are patients who use any antiepileptic drug, allergic reaction to pregabalin, severe hepatic, renal or gastrointestinal disorders, physciatric disorders, pregnants or breastfeeding,  NSAID or opioid drug use for a long time, diabetic or other neuropathic pain.
We randomize patients into two groups. 1) Pregabalin group 2) Control group
We give pregabalin 150 mg orally to pregabalin group patients two times (first dose 1 day before surgery., second dose 1 hour before surgery). We give placebo drug at the same times to the control group. We perform combined spinal epidural anesthesia  for surgery. we give 3 cc 0.5% hyperbaric bupivacaine for spinal anesthesia. We take blood samples for measurement of ischemia-reperfusion determinants, immediately before surgery, 5 minutes before tourniquet deflation, and 20 minutes after tourniquet deflation. 
We compare these results with appropriate statistical methods. </summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Baskent University Clinical Research Ethical Committee</ethicname>
      <ethicaddress>Taskent Caddesi 77. Sokak No:11 06490 Bahcelievler Cankaya Ankara</ethicaddress>
      <ethicapprovaldate>23/12/2016</ethicapprovaldate>
      <hrec>KA 16/10</hrec>
      <ethicsubmitdate />
      <ethiccountry>Turkey</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title>Mr</title>
      <name>Huseyin Ulas Pinar</name>
      <address>Baskent University Konya Research Center,Hocacihan mah. saray cad No:1 Selcuklu/ Konya Postal Code: 42080</address>
      <phone>+903322570606</phone>
      <fax />
      <email>huseyinpinar2@gmail.com</email>
      <country>Turkey</country>
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title>Mr</title>
      <name>Huseyin Ulas Pinar</name>
      <address>Baskent University Konya Research Center, Hocacihan mah. saray cad No:1 Selcuklu/ Konya Postal Code: 42080</address>
      <phone>+903322570606</phone>
      <fax />
      <email>huseyinpinar2@gmail.com</email>
      <country>Turkey</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title>Mr</title>
      <name>Huseyin Ulas Pinar</name>
      <address>Baskent University Konya Research Center, Hocacihan mah. saray cad No:1 Selcuklu/ Konya Postal Code: 42080</address>
      <phone>+903322570606</phone>
      <fax />
      <email>huseyinpinar2@gmail.com</email>
      <country>Turkey</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
  </contacts>
</ANZCTR_Trial>